Biblio Discovery — Demo Discovery Service

140 hasil untuk "Kulkarni, Anand"

Menampilkan 1–20 · 0,27 detik · RSS

  1. Buku Teks lengkap

    Handbook of AI-based Metaheuristics

    Kulkarni, Anand; Siarry, Patrick

    CRC Press · 2021 · Inggris · HAL

    International audience

  2. Artikel Jurnal Teks lengkap

    Elevated Liver Chemistries in COVID-19—Is It Not a Concern?

    Kumar, Karan; Kulkarni, Anand

    Am J Gastroenterol · 2020 · Inggris · PubMed Central

  3. Artikel Jurnal Teks lengkap

    Ascites in patients with end-stage renal disease: Challenges and solutions from diagnosis to management

    Roy, Akash; Kulkarni, Anand V.

    Hepatol Commun · 2025 · Inggris · PubMed Central

    Metabolic diseases have exponentially increased in recent years, which has led to an increased prevalence of metabolic dysfunction–associated steatotic liver disease and concomitant kidney diseases. Ascites are a common presentation of cirrhosis, and renal impairment in cirrhosis is well described…

  4. Artikel Jurnal Teks lengkap

    Optimal spectral templates for triggered feedback experiments

    Kulkarni, Anand S.; Troyer, Todd W.

    PLoS One · 2020 · Inggris · PubMed Central

    In the field of songbird neuroscience, researchers have used playback of aversive noise bursts to drive changes in song behavior for specific syllables within a bird’s song. Typically, a short (~5–10 msec) slice of the syllable is selected for targeting and the average spectrum of the slice is used…

  5. Artikel Jurnal Teks lengkap

    Pancreatico-pleural fistula: An unusual cause of chronic cough

    Kulkarni, Anand V.; Shasthry, Murali S.

    Indian J Med Res · 2019 · Inggris · PubMed Central

  6. Artikel Jurnal Teks lengkap

    Management of hepatitis B and C in special population

    Kulkarni, Anand V; Duvvuru, Nageshwar Reddy

    World J Gastroenterol · 2021 · Inggris · PubMed Central

    Chronic viral hepatitis is one of the leading causes of cirrhosis worldwide. Chronic hepatitis B is more common in the Asia-Pacific region due to the larger population and lower screening availability. Hepatitis C predominates in the west due to injection drug abuse. The discovery of (oral)…

  7. Artikel Jurnal Teks lengkap

    Screening for alcohol use disorder and monitoring for alcohol use in the liver clinic

    Kulkarni, Anand V.; Singal, Ashwani K.

    Clin Liver Dis (Hoboken) · 2023 · Inggris · PubMed Central

  8. Artikel Jurnal Teks lengkap

    The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease

    Kulkarni, Anand V.; Sarin, Shiv Kumar

    Ther Adv Endocrinol Metab · 2023 · Inggris · PubMed Central

    Nonalcoholic fatty liver disease (NAFLD), once considered a benign condition, has been associated with several cardiometabolic complications over the past two decades. The worldwide prevalence of NAFLD is as high as 30%. NAFLD requires the absence of a “significant alcohol intake.” Conflicting…

  9. Artikel Jurnal Teks lengkap

    Bleeding risk and thrombosis in cirrhosis: a paradox with a need to address them

    Kulkarni, Anand V.; Reddy, K. Rajender

    Hepatobiliary Surg Nutr · 2023 · Inggris · PubMed Central

  10. Artikel Jurnal Teks lengkap

    Rales Score, Apache Score and Terlipressin Non-response Predict Mortality in Patients with Critically Ill Cirrhosis, Pocus is a must for All Critically Ill Cirrhotic Patients on Terlipressin Plus Albumin

    Vedaghosh; Kulkarni, Anand V; Gupta, Anand

    Indian J Crit Care Med · 2024 · Inggris · PubMed Central

    BACKGROUND: The drug of choice in patients having cirrhosis with hepatorenal syndrome is Terlipressin with albumin (terli+alb) but Pulmonary overload is an adverse effect that we frequently notice in this combination. We wanted to assess the role of radiographic assessment of lung edema (RALE) and…

  11. Artikel Jurnal Teks lengkap

    Undergraduate medical education amidst volatility, uncertainty, complexity, ambiguity

    Camarata, Troy; Spizzieri, Angelina; Kulkarni, Anand

    Front Med (Lausanne) · 2025 · Inggris · PubMed Central

    Undergraduate medical education, especially in the United States, is being shaped by an environment that is changing at an unprecedented pace, creating new challenges for institutions, faculty, and students. For medical education to adapt to the changing environment, influencing factors must be…

  12. Artikel Jurnal Teks lengkap

    α-smooth muscle actin-positive fibroblasts correlate with poor survival in hepatocellular carcinoma

    PARIKH, JIGNESH G.; KULKARNI, ANAND; JOHNS, CAMEILA

    Oncol Lett · 2013 · Inggris · PubMed Central

    The current case-control study was conducted to assess the value of activated fibroblasts with high α-smooth muscle actin (α-SMA) expression as an indicator of survival in hepatocellular carcinoma (HCC) patients. In total, 47 patients diagnosed with HCC who underwent a liver biopsy at the Veterans…

  13. Artikel Jurnal Teks lengkap

    Management of Portal Hypertension

    Kulkarni, Anand V.; Rabiee, Atoosa; Mohanty, Arpan

    J Clin Exp Hepatol · 2022 · Inggris · PubMed Central

    Portal hypertension is the cause of the clinical complications associated with cirrhosis. The primary complications of portal hypertension are ascites, acute variceal bleed, and hepatic encephalopathy. Hepatic venous pressure gradient measurement remains the gold standard test for diagnosing…

  14. Artikel Jurnal Teks lengkap

    Updates in noncirrhotic portal hypertension

    Roy, Akash; Pasumarthy, Ashirwad; Kulkarni, Anand V.

    Clin Liver Dis (Hoboken) · 2023 · Inggris · PubMed Central

  15. Artikel Jurnal Teks lengkap

    Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision

    Singal, Amit G.; Ng, Michelle; Kulkarni, Anand

    J Clin Exp Hepatol · 2024 · Inggris · PubMed Central

    Hepatocellular carcinoma (HCC) is one of the few cancers with a 5-year survival that has remained below 20%; however, prognosis differs by tumor stage at diagnosis. Curative treatment options among patients with early-stage HCC afford a median survival of 5–10 years. Accordingly, international…